MUPIROCIN

MUPIROCIN was reported 14135 times

MUPIROCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 164 0.5413
1 NASAL VESTIBULITIS 17 0.1700
2 PURPURA SENILE 13 0.1066
3 BURKHOLDERIA TEST POSITIVE 13 0.1048
4 FEMALE GENITAL TRACT FISTULA 173 0.1012
5 RADICULOPATHY 175 0.0663
6 MACULAR DEGENERATION 760 0.0636
7 CHRONIC SINUSITIS 226 0.0602
8 PROCTITIS 165 0.0588
9 MATERNAL CONDITION AFFECTING FOETUS 12 0.0543
10 TARSAL TUNNEL SYNDROME 11 0.0500
11 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 48 0.0452
12 HUMIDITY INTOLERANCE 17 0.0425
13 TERATOGENICITY 12 0.0397
14 INTERCEPTED PRODUCT PRESCRIBING ERROR 42 0.0317
15 HYPERPARATHYROIDISM SECONDARY 72 0.0287
16 NEPHROGENIC ANAEMIA 122 0.0263
17 SEBORRHOEIC KERATOSIS 28 0.0193
18 REBOUND ACID HYPERSECRETION 57 0.0188
19 FOLATE DEFICIENCY 20 0.0173
20 VAGINAL DISCHARGE 166 0.0164
21 NASAL DISCHARGE DISCOLOURATION 22 0.0159
22 PARAESTHESIA ORAL 226 0.0157
23 IMPETIGO 23 0.0154
24 CLEFT LIP AND PALATE 17 0.0152
25 RESORPTION BONE INCREASED 12 0.0146
26 BONE DEMINERALISATION 15 0.0142
27 ORAL CANDIDIASIS 185 0.0140
28 TRACHEITIS 10 0.0131
29 BODY TEMPERATURE ABNORMAL 24 0.0130
30 SKIN WEEPING 45 0.0126
31 CUTANEOUS T-CELL LYMPHOMA 14 0.0111
32 INFUSION SITE DISCHARGE 19 0.0108
33 GROIN ABSCESS 12 0.0102
34 INFUSION SITE BRUISING 22 0.0102
35 END STAGE RENAL DISEASE 185 0.0101
36 INFUSION SITE MASS 11 0.0101
37 ANAEMIA OF CHRONIC DISEASE 9 0.0100
38 ASPERGILLOSIS 13 0.0099
39 RHINALGIA 27 0.0098
40 TOOTH EROSION 12 0.0098
41 STAPHYLOCOCCAL SKIN INFECTION 12 0.0098
42 PERIRECTAL ABSCESS 10 0.0090
43 VESTIBULAR DISORDER 11 0.0090
44 XEROSIS 11 0.0089
45 LUMBAR RADICULOPATHY 10 0.0086
46 LINEAR IGA DISEASE 14 0.0084
47 SINUS OPERATION 20 0.0084
48 FOOD AVERSION 14 0.0082
49 PROCEDURAL PAIN 219 0.0079
50 SEBORRHOEIC DERMATITIS 13 0.0079
51 CHRONIC KIDNEY DISEASE 582 0.0077
52 INFUSION SITE PRURITUS 24 0.0076
53 PRODUCT PRESCRIBING ISSUE 163 0.0075
54 SKIN INFECTION 80 0.0071
55 FREQUENT BOWEL MOVEMENTS 188 0.0070
56 PUSTULE 16 0.0067
57 NASAL SEPTUM DEVIATION 13 0.0066
58 ESSENTIAL HYPERTENSION 12 0.0066
59 SKIN WOUND 11 0.0065
60 VERTIGO POSITIONAL 11 0.0063
61 DERMAL CYST 15 0.0061
62 RECALLED PRODUCT ADMINISTERED 57 0.0060
63 INGROWING NAIL 14 0.0059
64 NEURODERMATITIS 22 0.0059
65 COLITIS 212 0.0056
66 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 92 0.0054
67 CHEILITIS 29 0.0054
68 HORDEOLUM 23 0.0053
69 THROMBOPHLEBITIS SUPERFICIAL 16 0.0053
70 PAPULE 37 0.0052
71 APPLICATION SITE PAIN 115 0.0052
72 STAPHYLOCOCCAL INFECTION 169 0.0051
73 SEASONAL ALLERGY 72 0.0051
74 SKIN ABRASION 24 0.0051
75 PARANASAL SINUS DISCOMFORT 19 0.0050
76 RECTAL HAEMORRHAGE 215 0.0050
77 SKIN HAEMORRHAGE 74 0.0050
78 CLOSTRIDIUM TEST POSITIVE 11 0.0050
79 MULTIPLE ALLERGIES 39 0.0050
80 SKIN FISSURES 97 0.0050
81 WOUND COMPLICATION 17 0.0049
82 EYELID PAIN 10 0.0049
83 ANHEDONIA 129 0.0049
84 DEVICE INFUSION ISSUE 12 0.0048
85 SKIN DISCOMFORT 13 0.0048
86 ECONOMIC PROBLEM 72 0.0047
87 SCAB 54 0.0047
88 NASAL DISCOMFORT 37 0.0047
89 BLOOD CHLORIDE DECREASED 12 0.0046
90 SQUAMOUS CELL CARCINOMA OF SKIN 28 0.0046
91 DERMATITIS ATOPIC 244 0.0046
92 ACTINIC KERATOSIS 12 0.0046
93 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 25 0.0046
94 MELANOCYTIC NAEVUS 20 0.0046
95 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 76 0.0045
96 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 316 0.0044
97 BLOOD IMMUNOGLOBULIN G DECREASED 11 0.0044
98 COLITIS ULCERATIVE 194 0.0043
99 PRODUCT PHYSICAL CONSISTENCY ISSUE 24 0.0043
100 INFUSION SITE HAEMORRHAGE 14 0.0043
101 TUBULOINTERSTITIAL NEPHRITIS 79 0.0042
102 PLANTAR FASCIITIS 14 0.0042
103 SUBCUTANEOUS ABSCESS 20 0.0042
104 HIDRADENITIS 38 0.0042
105 OSTEOPENIA 63 0.0041
106 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
107 PARONYCHIA 18 0.0041
108 WOUND SECRETION 16 0.0041
109 RENAL TUBULAR NECROSIS 40 0.0041
110 ARTHROPOD BITE 30 0.0040
111 SKIN EROSION 13 0.0040
112 INFUSION SITE ERYTHEMA 34 0.0040
113 UPPER-AIRWAY COUGH SYNDROME 33 0.0040
114 MACULE 11 0.0040
115 SKIN LACERATION 43 0.0040
116 PRODUCT ADMINISTRATION INTERRUPTED 31 0.0039
117 SCRATCH 41 0.0039
118 DERMATITIS CONTACT 43 0.0038
119 ABSCESS LIMB 16 0.0038
120 ANIMAL BITE 10 0.0037
121 HAEMATOCHEZIA 204 0.0037
122 NECROTISING FASCIITIS 13 0.0037
123 PRE-EXISTING CONDITION IMPROVED 23 0.0037
124 PRODUCT USE IN UNAPPROVED INDICATION 901 0.0036
125 INFUSION RELATED REACTION 239 0.0036
126 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 66 0.0036
127 EAR PAIN 70 0.0036
128 RHINOVIRUS INFECTION 14 0.0036
129 DERMATITIS 75 0.0036
130 SKIN LESION 98 0.0036
131 BLOOD BLISTER 11 0.0035
132 ODYNOPHAGIA 21 0.0035
133 NASAL DRYNESS 22 0.0035
134 INFUSION SITE SWELLING 22 0.0035
135 CONCUSSION 27 0.0035
136 SNORING 13 0.0034
137 RENAL FAILURE 455 0.0034
138 APPLICATION SITE SWELLING 17 0.0034
139 PARANASAL SINUS HYPERSECRETION 13 0.0034
140 RENAL INJURY 101 0.0034
141 TENDERNESS 35 0.0034
142 SKIN ULCER 86 0.0033
143 LOCALISED INFECTION 80 0.0033
144 SPINAL OSTEOARTHRITIS 29 0.0033
145 CELLULITIS 163 0.0032
146 PHARYNGITIS STREPTOCOCCAL 35 0.0032
147 HYPERCHLORHYDRIA 19 0.0032
148 FUNGAL SKIN INFECTION 13 0.0032
149 SECRETION DISCHARGE 40 0.0032
150 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 93 0.0032
151 BLOOD URIC ACID INCREASED 18 0.0031
152 HYPOPHOSPHATAEMIA 23 0.0031
153 SKIN SWELLING 27 0.0031
154 INFUSION SITE PAIN 40 0.0031
155 SKIN WARM 18 0.0031
156 SINUS DISORDER 61 0.0031
157 PIGMENTATION DISORDER 19 0.0031
158 INSURANCE ISSUE 47 0.0031
159 PURULENT DISCHARGE 13 0.0030
160 LIGAMENT SPRAIN 30 0.0030
161 PSEUDOMONAS INFECTION 26 0.0030
162 ACUTE RESPIRATORY FAILURE 58 0.0030
163 ACCIDENT 36 0.0030
164 EAR INFECTION 79 0.0030
165 DYSPEPSIA 291 0.0030
166 INCORRECT ROUTE OF DRUG ADMINISTRATION 105 0.0029
167 ECZEMA 153 0.0029
168 SINUSITIS 299 0.0029
169 CONJUNCTIVITIS 54 0.0029
170 FURUNCLE 23 0.0029
171 ENTEROCOCCAL INFECTION 14 0.0029
172 SQUAMOUS CELL CARCINOMA 27 0.0029
173 SCAR 49 0.0029
174 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
175 ACUTE KIDNEY INJURY 436 0.0028
176 MUSCLE DISORDER 23 0.0028
177 HYPERVOLAEMIA 14 0.0028
178 SYNOVIAL CYST 13 0.0028
179 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
180 EXERCISE TOLERANCE DECREASED 16 0.0028
181 SINUS CONGESTION 37 0.0027
182 APPLICATION SITE DISCOLOURATION 11 0.0027
183 UPPER RESPIRATORY TRACT INFECTION 125 0.0027
184 RHINITIS ALLERGIC 12 0.0027
185 PERIPHERAL VENOUS DISEASE 11 0.0027
186 BLOOD MAGNESIUM DECREASED 23 0.0027
187 SPINAL STENOSIS 11 0.0027
188 EYE INFECTION 30 0.0027
189 LIMB INJURY 72 0.0026
190 STAPHYLOCOCCAL SEPSIS 13 0.0026
191 DIABETIC NEUROPATHY 13 0.0026
192 ATTENTION DEFICIT HYPERACTIVITY DISORDER 11 0.0026
193 THYROID MASS 10 0.0026
194 MAJOR DEPRESSION 19 0.0026
195 INTERCEPTED MEDICATION ERROR 12 0.0026
196 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
197 AORTIC STENOSIS 9 0.0026
198 ROSACEA 12 0.0026
199 APPETITE DISORDER 17 0.0026
200 VITAMIN D DEFICIENCY 25 0.0026
201 DRUG ADMINISTERED AT INAPPROPRIATE SITE 27 0.0026
202 ESCHERICHIA INFECTION 21 0.0026
203 SKIN EXFOLIATION 215 0.0025
204 GASTROENTERITIS VIRAL 46 0.0025
205 PROSTATOMEGALY 10 0.0025
206 HAND FRACTURE 18 0.0025
207 HYPERKERATOSIS 14 0.0025
208 BACTERAEMIA 30 0.0025
209 PERIPHERAL VASCULAR DISORDER 13 0.0025
210 AZOTAEMIA 10 0.0025
211 FACIAL BONES FRACTURE 9 0.0025
212 ATELECTASIS 24 0.0025
213 WOUND 69 0.0025
214 CUTANEOUS VASCULITIS 9 0.0025
215 TOOTH ABSCESS 25 0.0025
216 ANAL INCONTINENCE 22 0.0024
217 HEPARIN-INDUCED THROMBOCYTOPENIA 12 0.0024
218 VASCULAR DEVICE INFECTION 11 0.0024
219 SCOLIOSIS 15 0.0024
220 IMPAIRED GASTRIC EMPTYING 33 0.0024
221 INFUSION SITE EXTRAVASATION 15 0.0024
222 SNEEZING 54 0.0024
223 PRODUCT PRESCRIBING ERROR 57 0.0024
224 BREAST MASS 16 0.0024
225 ABSCESS 38 0.0024
226 SKIN PLAQUE 20 0.0024
227 SKIN CANCER 51 0.0024
228 ORAL HERPES 46 0.0024
229 PHLEBITIS 12 0.0023
230 GASTROINTESTINAL INFECTION 21 0.0023
231 RESPIRATORY TRACT INFECTION 61 0.0023
232 RENAL FAILURE CHRONIC 18 0.0023
233 EPISTAXIS 175 0.0023
234 POST PROCEDURAL INFECTION 19 0.0023
235 DECUBITUS ULCER 19 0.0023
236 TOXIC EPIDERMAL NECROLYSIS 35 0.0023
237 IRON DEFICIENCY ANAEMIA 21 0.0023
238 SKIN ATROPHY 13 0.0023
239 POST-TRAUMATIC STRESS DISORDER 15 0.0022
240 MALNUTRITION 25 0.0022
241 SWELLING OF EYELID 14 0.0022
242 HOSPICE CARE 22 0.0022
243 FOOT FRACTURE 42 0.0022
244 RHINORRHOEA 142 0.0022
245 LUMBAR VERTEBRAL FRACTURE 10 0.0022
246 BLISTER 122 0.0022
247 GANGRENE 13 0.0022
248 ARTHRITIS INFECTIVE 10 0.0022
249 HEART RATE ABNORMAL 12 0.0021
250 SLEEP APNOEA SYNDROME 41 0.0021
251 NEPHROPATHY 20 0.0021
252 KIDNEY INFECTION 42 0.0021
253 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
254 TOOTH INFECTION 28 0.0021
255 PEMPHIGOID 16 0.0021
256 FAILURE TO THRIVE 11 0.0021
257 BASAL CELL CARCINOMA 33 0.0021
258 ARTERIOSCLEROSIS CORONARY ARTERY 14 0.0021
259 WOUND INFECTION 23 0.0021
260 SKIN MASS 14 0.0021
261 RIB FRACTURE 43 0.0021
262 MOUTH SWELLING 12 0.0021
263 DENTAL CARIES 23 0.0021
264 NASAL CONGESTION 122 0.0021
265 OSTEOARTHRITIS 88 0.0021
266 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
267 POSTOPERATIVE WOUND INFECTION 14 0.0021
268 DYSPNOEA EXERTIONAL 78 0.0021
269 SKIN DISORDER 69 0.0021
270 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
271 INCREASED TENDENCY TO BRUISE 19 0.0021
272 DIVERTICULUM INTESTINAL 9 0.0021
273 HYPOVOLAEMIA 12 0.0020
274 GROIN PAIN 18 0.0020
275 ERYTHEMA 421 0.0020
276 ORAL DISORDER 15 0.0020
277 MOUTH HAEMORRHAGE 15 0.0020
278 WEIGHT DECREASED 571 0.0020
279 PHARYNGEAL SWELLING 20 0.0020
280 BONE DENSITY DECREASED 64 0.0020
281 PAIN OF SKIN 55 0.0020
282 FOREIGN BODY SENSATION IN EYES 13 0.0020
283 BACTERIAL INFECTION 38 0.0020
284 PRODUCT USE ISSUE 382 0.0020
285 FACIAL PAIN 18 0.0020
286 PULMONARY MASS 30 0.0020
287 BRONCHITIS 149 0.0020
288 HYPERNATRAEMIA 10 0.0020
289 OSTEOPOROSIS 82 0.0020
290 FLUID OVERLOAD 29 0.0020
291 PRODUCTIVE COUGH 95 0.0020
292 CYSTIC FIBROSIS 11 0.0020
293 BRAIN FOG 31 0.0020
294 PRODUCT DOSE OMISSION IN ERROR 56 0.0020
295 KLEBSIELLA INFECTION 10 0.0020
296 THERMAL BURN 14 0.0020
297 SKIN DISCOLOURATION 90 0.0020
298 ANAEMIA 371 0.0019
299 FOOD ALLERGY 15 0.0019
300 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 12 0.0019
301 BLOOD IRON DECREASED 23 0.0019
302 POOR VENOUS ACCESS 20 0.0019
303 KNEE OPERATION 19 0.0019
304 DRY SKIN 257 0.0019
305 WRIST FRACTURE 23 0.0019
306 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 13 0.0019
307 DRY EYE 95 0.0019
308 GASTROOESOPHAGEAL REFLUX DISEASE 153 0.0019
309 SENSITIVE SKIN 14 0.0019
310 GOUT 34 0.0019
311 NECK PAIN 105 0.0019
312 ORAL PAIN 42 0.0019
313 VITAMIN D DECREASED 16 0.0019
314 PATHOGEN RESISTANCE 17 0.0019
315 COVID-19 PNEUMONIA 22 0.0019
316 BLOOD POTASSIUM DECREASED 56 0.0019
317 FUNGAL INFECTION 62 0.0019
318 ANAL ABSCESS 10 0.0019
319 CYST 23 0.0019
320 APPLICATION SITE PRURITUS 42 0.0018
321 CONSTIPATION 402 0.0018
322 INTERVERTEBRAL DISC DEGENERATION 17 0.0018
323 CANDIDA INFECTION 31 0.0018
324 ABNORMAL FAECES 15 0.0018
325 RESPIRATORY TRACT CONGESTION 29 0.0018
326 OSTEOMYELITIS 33 0.0018
327 ABDOMINAL TENDERNESS 9 0.0018
328 PHOTOPHOBIA 34 0.0018
329 SPUTUM DISCOLOURED 17 0.0018
330 MENISCUS INJURY 11 0.0018
331 BRONCHIECTASIS 12 0.0018
332 PERIORBITAL SWELLING 10 0.0018
333 CHOLECYSTITIS ACUTE 10 0.0018
334 HIP ARTHROPLASTY 27 0.0018
335 ECCHYMOSIS 12 0.0017
336 AUTOIMMUNE DISORDER 17 0.0017
337 ONYCHOCLASIS 12 0.0017
338 RHINITIS 14 0.0017
339 HERPES VIRUS INFECTION 10 0.0017
340 LYMPHOEDEMA 12 0.0017
341 EYE DISCHARGE 18 0.0017
342 THERAPY PARTIAL RESPONDER 27 0.0017
343 ILLNESS 178 0.0017
344 PRODUCT DISTRIBUTION ISSUE 16 0.0017
345 HERPES ZOSTER 99 0.0017
346 TRANSFUSION 18 0.0017
347 APPLICATION SITE ERYTHEMA 45 0.0017
348 VASCULITIS 20 0.0017
349 TOOTHACHE 31 0.0017
350 RASH PRURITIC 92 0.0017
351 HERPES SIMPLEX 11 0.0017
352 HYPOPHAGIA 43 0.0017
353 IMMUNE SYSTEM DISORDER 22 0.0017
354 ABDOMINAL PAIN 388 0.0017
355 CARDIAC FAILURE ACUTE 11 0.0016
356 DIZZINESS POSTURAL 16 0.0016
357 RASH PUSTULAR 12 0.0016
358 INGUINAL HERNIA 10 0.0016
359 CHOLECYSTITIS CHRONIC 11 0.0016
360 CARPAL TUNNEL SYNDROME 23 0.0016
361 ROTATOR CUFF SYNDROME 21 0.0016
362 PULMONARY HYPERTENSION 34 0.0016
363 ATRIAL FLUTTER 13 0.0016
364 PRURITUS 626 0.0016
365 SPINAL OPERATION 20 0.0016
366 VIRAL INFECTION 54 0.0016
367 HIATUS HERNIA 21 0.0016
368 HYPOXIA 57 0.0016
369 CARDIAC MURMUR 14 0.0016
370 SLEEP DISORDER 114 0.0016
371 ANKLE FRACTURE 25 0.0016
372 INTENTIONAL DOSE OMISSION 46 0.0016
373 BLOOD UREA INCREASED 27 0.0016
374 PERIPHERAL SWELLING 248 0.0016
375 EYE PRURITUS 54 0.0016
376 RASH MACULAR 56 0.0016
377 FLANK PAIN 15 0.0016
378 IMPAIRED QUALITY OF LIFE 23 0.0016
379 URINARY TRACT INFECTION 272 0.0016
380 MITRAL VALVE INCOMPETENCE 18 0.0016
381 HYPERLIPIDAEMIA 19 0.0016
382 MULTIPLE INJURIES 10 0.0016
383 HEAD INJURY 50 0.0016
384 CHOLECYSTECTOMY 18 0.0016
385 NEPHROLITHIASIS 72 0.0016
386 PYREXIA 543 0.0016
387 PROCTALGIA 10 0.0016
388 SURGERY 91 0.0016
389 DIVERTICULUM 11 0.0015
390 JOINT INJURY 33 0.0015
391 FEAR OF INJECTION 11 0.0015
392 PELVIC FRACTURE 12 0.0015
393 THROAT IRRITATION 69 0.0015
394 CONTUSION 148 0.0015
395 GENERALISED OEDEMA 19 0.0015
396 PSORIASIS 200 0.0015
397 FOLLICULITIS 16 0.0015
398 PAIN 932 0.0015
399 OEDEMA 82 0.0015
400 BURNING SENSATION 106 0.0015
401 RENAL CYST 12 0.0015
402 TRICUSPID VALVE INCOMPETENCE 12 0.0015
403 DYSSTASIA 44 0.0015
404 OXYGEN SATURATION DECREASED 84 0.0015
405 INJECTION SITE IRRITATION 19 0.0015
406 DYSPHONIA 87 0.0015
407 NAIL DISORDER 13 0.0015
408 BURSITIS 18 0.0015
409 DECREASED ACTIVITY 16 0.0015
410 BONE DISORDER 27 0.0015
411 NEURALGIA 36 0.0015
412 TASTE DISORDER 30 0.0015
413 BACK DISORDER 24 0.0015
414 CYSTITIS 47 0.0015
415 BIPOLAR DISORDER 16 0.0015
416 OROPHARYNGEAL PAIN 136 0.0015
417 WHEEZING 87 0.0015
418 EXPOSURE VIA SKIN CONTACT 38 0.0015
419 RESPIRATORY RATE INCREASED 13 0.0015
420 EMOTIONAL DISTRESS 177 0.0015
421 IMPAIRED HEALING 48 0.0015
422 PAROSMIA 11 0.0015
423 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76 0.0015
424 FLUID RETENTION 74 0.0015
425 MUCOSAL INFLAMMATION 38 0.0014
426 PULMONARY ARTERIAL HYPERTENSION 21 0.0014
427 DISCOMFORT 88 0.0014
428 RASH 628 0.0014
429 MATERNAL DRUGS AFFECTING FOETUS 11 0.0014
430 BLOOD SODIUM DECREASED 27 0.0014
431 PNEUMONIA 461 0.0014
432 INFECTION 206 0.0014
433 HYPOALBUMINAEMIA 11 0.0014
434 COUGH 396 0.0014
435 HAEMATOCRIT DECREASED 28 0.0014
436 ROAD TRAFFIC ACCIDENT 59 0.0014
437 UROSEPSIS 13 0.0014
438 COVID-19 246 0.0014
439 ADRENAL INSUFFICIENCY 17 0.0014
440 INTERNAL HAEMORRHAGE 16 0.0014
441 IRRITABLE BOWEL SYNDROME 30 0.0014
442 PRODUCT DOSE OMISSION ISSUE 411 0.0014
443 NIGHT SWEATS 45 0.0014
444 CARDIAC OPERATION 12 0.0014
445 MUSCULOSKELETAL DISCOMFORT 24 0.0014
446 MIGRAINE 133 0.0014
447 PSYCHOLOGICAL TRAUMA 12 0.0014
448 ANXIETY 395 0.0014
449 BLOOD ALBUMIN DECREASED 11 0.0014
450 ENCEPHALOPATHY 34 0.0014
451 CARDIOMEGALY 17 0.0014
452 LEUKOCYTOSIS 25 0.0014
453 DERMATITIS BULLOUS 10 0.0014
454 CONDITION AGGRAVATED 420 0.0014
455 SCIATICA 22 0.0014
456 PSORIATIC ARTHROPATHY 56 0.0014
457 NODULE 18 0.0014
458 NEUROPATHY PERIPHERAL 131 0.0014
459 OCULAR HYPERAEMIA 65 0.0014
460 APPLICATION SITE IRRITATION 17 0.0014
461 EYE PAIN 77 0.0014
462 TOOTH FRACTURE 15 0.0014
463 PRODUCT COMMUNICATION ISSUE 12 0.0014
464 RASH ERYTHEMATOUS 65 0.0014
465 SEPTIC SHOCK 59 0.0014
466 EYE IRRITATION 78 0.0014
467 LOWER LIMB FRACTURE 26 0.0014
468 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
469 TOOTH DISORDER 30 0.0013
470 NERVE INJURY 15 0.0013
471 HYPERCHOLESTEROLAEMIA 13 0.0013
472 MALIGNANT MELANOMA 18 0.0013
473 SUNBURN 10 0.0013
474 WEIGHT FLUCTUATION 14 0.0013
475 SEPSIS 149 0.0013
476 STOMATITIS 81 0.0013
477 JOINT STIFFNESS 35 0.0013
478 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
479 CLOSTRIDIUM DIFFICILE INFECTION 29 0.0013
480 INFLUENZA 148 0.0013
481 THERAPEUTIC RESPONSE SHORTENED 44 0.0013
482 INCONTINENCE 14 0.0013
483 FIBROMYALGIA 32 0.0013
484 TROPONIN INCREASED 10 0.0013
485 EXOSTOSIS 12 0.0013
486 BODY HEIGHT DECREASED 14 0.0013
487 WHITE BLOOD CELL COUNT INCREASED 50 0.0013
488 DROOLING 9 0.0013
489 GASTROENTERITIS 19 0.0013
490 DRUG PRESCRIBING ERROR 25 0.0013
491 GLAUCOMA 25 0.0013
492 OEDEMA PERIPHERAL 158 0.0013
493 ASTHMA 146 0.0013
494 MASS 18 0.0013
495 BACK INJURY 14 0.0013
496 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
497 SARS-COV-2 TEST POSITIVE 17 0.0013
498 CARDIOMYOPATHY 19 0.0013
499 SKIN HYPERPIGMENTATION 11 0.0013
500 MULTIPLE FRACTURES 21 0.0013
501 MUSCLE STRAIN 11 0.0013
502 SPINAL DISORDER 12 0.0013
503 QUALITY OF LIFE DECREASED 17 0.0013
504 EAR DISCOMFORT 13 0.0013
505 MUSCLE ATROPHY 16 0.0013
506 PRODUCT PACKAGING ISSUE 12 0.0013
507 RED BLOOD CELL COUNT DECREASED 36 0.0013
508 URINE OUTPUT DECREASED 11 0.0013
509 ULCER 20 0.0013
510 HYPERSOMNIA 36 0.0013
511 OBESITY 20 0.0013
512 CORONARY ARTERY DISEASE 38 0.0013
513 HYPERKALAEMIA 44 0.0013
514 POOR QUALITY SLEEP 27 0.0013
515 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 225 0.0012
516 SPINAL FRACTURE 25 0.0012
517 OCULAR DISCOMFORT 14 0.0012
518 POLLAKIURIA 52 0.0012
519 FISTULA 14 0.0012
520 BLOOD CALCIUM DECREASED 14 0.0012
521 PNEUMONIA ASPIRATION 31 0.0012
522 DECREASED APPETITE 288 0.0012
523 SWELLING 116 0.0012
524 EXPIRED PRODUCT ADMINISTERED 41 0.0012
525 HEADACHE 773 0.0012
526 MUSCULOSKELETAL CHEST PAIN 19 0.0012
527 GAIT INABILITY 41 0.0012
528 LACRIMATION INCREASED 37 0.0012
529 CEREBRAL DISORDER 9 0.0012
530 PHARYNGITIS 15 0.0012
531 ILEUS 15 0.0012
532 TOOTH LOSS 25 0.0012
533 NAUSEA 954 0.0012
534 ELECTROLYTE IMBALANCE 14 0.0012
535 LETHARGY 69 0.0012
536 PNEUMONIA BACTERIAL 11 0.0012
537 POST PROCEDURAL COMPLICATION 23 0.0012
538 SINUS TACHYCARDIA 17 0.0012
539 ARTHRITIS 94 0.0012
540 OESOPHAGITIS 13 0.0012
541 PERITONITIS BACTERIAL 12 0.0012
542 EYE SWELLING 44 0.0012
543 PRODUCT DOSE OMISSION 77 0.0012
544 BLOOD CREATININE INCREASED 77 0.0012
545 RESPIRATORY FAILURE 86 0.0012
546 GALLBLADDER DISORDER 21 0.0012
547 MALAISE 515 0.0012
548 EATING DISORDER 25 0.0012
549 FALL 390 0.0012
550 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
551 LACERATION 11 0.0012
552 DEVICE RELATED INFECTION 18 0.0012
553 ARTERIOSCLEROSIS 11 0.0012
554 APHTHOUS ULCER 9 0.0012
555 ATRIAL FIBRILLATION 113 0.0012
556 RESPIRATORY DISTRESS 32 0.0012
557 BLOOD URINE PRESENT 22 0.0012
558 SKIN IRRITATION 53 0.0012
559 DRUG INEFFECTIVE 1522 0.0012
560 RESTLESS LEGS SYNDROME 21 0.0012
561 PYELONEPHRITIS 10 0.0012
562 BACK PAIN 268 0.0012
563 MENTAL STATUS CHANGES 32 0.0012
564 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
565 HAEMOPTYSIS 32 0.0011
566 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
567 INTERVERTEBRAL DISC PROTRUSION 25 0.0011
568 CYTOPENIA 14 0.0011
569 IMMUNODEFICIENCY 17 0.0011
570 COAGULOPATHY 19 0.0011
571 RESPIRATORY DISORDER 34 0.0011
572 PLEURAL EFFUSION 69 0.0011
573 LIMB DISCOMFORT 35 0.0011
574 DEPRESSION 257 0.0011
575 OFF LABEL USE 988 0.0011
576 HAEMORRHOIDS 22 0.0011
577 TOOTH EXTRACTION 14 0.0011
578 DIVERTICULITIS 31 0.0011
579 RASH PAPULAR 25 0.0011
580 CARDIOGENIC SHOCK 16 0.0011
581 DERMATITIS ALLERGIC 14 0.0011
582 UNEVALUABLE EVENT 84 0.0011
583 SPINAL PAIN 13 0.0011
584 OROPHARYNGEAL DISCOMFORT 10 0.0011
585 BLOOD PRESSURE ABNORMAL 22 0.0011
586 DIARRHOEA 712 0.0011
587 PULMONARY THROMBOSIS 12 0.0011
588 BLOOD PRESSURE INCREASED 168 0.0011
589 GINGIVAL BLEEDING 15 0.0011
590 ASPIRATION 12 0.0011
591 RENAL IMPAIRMENT 92 0.0011
592 PAIN IN JAW 31 0.0011
593 MOUTH ULCERATION 23 0.0011
594 EMPHYSEMA 11 0.0011
595 ARTHRALGIA 453 0.0011
596 PROSTATIC SPECIFIC ANTIGEN INCREASED 15 0.0011
597 PRODUCT ADMINISTRATION ERROR 22 0.0011
598 HIP FRACTURE 35 0.0011
599 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
600 DYSURIA 40 0.0011
601 INFLAMMATION 56 0.0011
602 NERVE COMPRESSION 10 0.0011
603 HEART RATE INCREASED 107 0.0011
604 EOSINOPHIL COUNT INCREASED 9 0.0011
605 DRUG EFFECT LESS THAN EXPECTED 16 0.0011
606 DEHYDRATION 144 0.0011
607 HYPOMAGNESAEMIA 15 0.0011
608 FLATULENCE 61 0.0011
609 APHONIA 15 0.0011
610 HEAD DISCOMFORT 19 0.0011
611 INITIAL INSOMNIA 11 0.0011
612 THERAPEUTIC RESPONSE DECREASED 65 0.0011
613 LIVER FUNCTION TEST INCREASED 23 0.0011
614 CARDIAC FAILURE CONGESTIVE 86 0.0011
615 CHOLELITHIASIS 35 0.0011
616 MUSCULAR WEAKNESS 121 0.0011
617 GASTRITIS 28 0.0011
618 FATIGUE 827 0.0011
619 DEEP VEIN THROMBOSIS 69 0.0011
620 HYPOKALAEMIA 49 0.0011
621 WHITE BLOOD CELL COUNT DECREASED 115 0.0011
622 MUSCLE SPASTICITY 13 0.0011
623 FEBRILE NEUTROPENIA 70 0.0011
624 UPPER LIMB FRACTURE 21 0.0011
625 PALPITATIONS 123 0.0010
626 SUBDURAL HAEMATOMA 15 0.0010
627 BLOOD POTASSIUM INCREASED 17 0.0010
628 DRUG DISPENSING ERROR 16 0.0010
629 INJECTION SITE SWELLING 79 0.0010
630 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
631 HEREDITARY ANGIOEDEMA 11 0.0010
632 CYTOMEGALOVIRUS INFECTION 17 0.0010
633 PANCYTOPENIA 57 0.0010
634 THINKING ABNORMAL 19 0.0010
635 BALANCE DISORDER 88 0.0010
636 PAIN IN EXTREMITY 298 0.0010
637 MENTAL DISORDER 44 0.0010
638 PRODUCT DISPENSING ERROR 22 0.0010
639 MUSCLE SPASMS 185 0.0010
640 CATARACT 60 0.0010
641 THERAPY INTERRUPTED 72 0.0010
642 ORAL DISCOMFORT 14 0.0010
643 PULMONARY OEDEMA 45 0.0010
644 HYPOCALCAEMIA 19 0.0010
645 HYPOAESTHESIA 150 0.0010
646 DYSPHAGIA 95 0.0010
647 BLOOD PRESSURE FLUCTUATION 24 0.0010
648 SALIVARY HYPERSECRETION 10 0.0010
649 NASOPHARYNGITIS 184 0.0010
650 ASTHENIA 375 0.0010
651 MEMORY IMPAIRMENT 137 0.0010
652 JOINT SWELLING 120 0.0010
653 BLOOD PRESSURE DECREASED 66 0.0010
654 MUSCULOSKELETAL PAIN 52 0.0010
655 FULL BLOOD COUNT DECREASED 20 0.0010
656 BLOOD COUNT ABNORMAL 15 0.0010
657 SEIZURE 114 0.0010
658 SWELLING FACE 64 0.0010
659 HOSPITALISATION 151 0.0010
660 LABORATORY TEST ABNORMAL 29 0.0010
661 HERNIA 19 0.0010
662 INTESTINAL OBSTRUCTION 37 0.0010
663 MOTOR DYSFUNCTION 10 0.0010
664 URINARY INCONTINENCE 29 0.0010
665 ABDOMINAL DISCOMFORT 164 0.0010
666 URTICARIA 163 0.0010
667 GAIT DISTURBANCE 186 0.0010
668 FEELING COLD 27 0.0010
669 TEMPERATURE INTOLERANCE 10 0.0010
670 HEPATIC STEATOSIS 18 0.0010
671 PERITONITIS 20 0.0010
672 MICTURITION URGENCY 11 0.0010
673 DYSPNOEA 545 0.0010
674 AGEUSIA 24 0.0010
675 PETECHIAE 10 0.0010
676 NEOPLASM 11 0.0010
677 DEAFNESS 25 0.0010
678 MELAENA 21 0.0010
679 PRESCRIBED UNDERDOSE 19 0.0010
680 INJECTION SITE DISCOMFORT 10 0.0009
681 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
682 VISION BLURRED 130 0.0009
683 POST PROCEDURAL HAEMORRHAGE 11 0.0009
684 THROMBOSIS 76 0.0009
685 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 22 0.0009
686 WEIGHT INCREASED 210 0.0009
687 FEEDING DISORDER 19 0.0009
688 DRY MOUTH 76 0.0009
689 THERAPEUTIC RESPONSE UNEXPECTED 42 0.0009
690 TINNITUS 43 0.0009
691 LIP SWELLING 31 0.0009
692 FEAR 25 0.0009
693 HYPOAESTHESIA ORAL 14 0.0009
694 INJURY 65 0.0009
695 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
696 VISUAL IMPAIRMENT 114 0.0009
697 ASCITES 27 0.0009
698 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
699 INJECTION SITE RASH 28 0.0009
700 THERAPY NON-RESPONDER 41 0.0009
701 DISABILITY 18 0.0009
702 ABDOMINAL DISTENSION 95 0.0009
703 BLOOD TRIGLYCERIDES INCREASED 16 0.0009
704 ADVERSE DRUG REACTION 81 0.0009
705 ANOSMIA 13 0.0009
706 CHEST PAIN 166 0.0009
707 DISEASE PROGRESSION 106 0.0009
708 GLOMERULAR FILTRATION RATE DECREASED 11 0.0009
709 JOINT RANGE OF MOTION DECREASED 12 0.0009
710 MYALGIA 152 0.0009
711 CONTRAINDICATED PRODUCT ADMINISTERED 27 0.0009
712 UNRESPONSIVE TO STIMULI 23 0.0009
713 INCORRECT DRUG ADMINISTRATION DURATION 25 0.0009
714 HYPERTENSION 188 0.0009
715 HYPOTENSION 178 0.0009
716 VERTIGO 54 0.0009
717 DRY THROAT 9 0.0009
718 NO ADVERSE EVENT 160 0.0009
719 PNEUMOTHORAX 14 0.0009
720 EYE DISORDER 29 0.0009
721 PLATELET COUNT DECREASED 94 0.0009
722 CRYING 32 0.0009
723 INJECTION SITE DISCOLOURATION 11 0.0009
724 MYOCARDIAL ISCHAEMIA 10 0.0009
725 ERUCTATION 17 0.0009
726 HYPOTHYROIDISM 28 0.0009
727 GASTROINTESTINAL HAEMORRHAGE 73 0.0009
728 ACCIDENTAL EXPOSURE TO PRODUCT 90 0.0009
729 CHOKING 17 0.0009
730 ANAPHYLACTIC REACTION 48 0.0009
731 HALLUCINATION 65 0.0009
732 CHILLS 101 0.0009
733 ALOPECIA 169 0.0009
734 RENAL DISORDER 40 0.0009
735 SPLENOMEGALY 10 0.0009
736 SKIN REACTION 12 0.0009
737 ABDOMINAL PAIN UPPER 175 0.0008
738 THROMBOCYTOPENIA 95 0.0008
739 LYMPHOCYTE COUNT DECREASED 15 0.0008
740 PHOTOSENSITIVITY REACTION 14 0.0008
741 DIALYSIS 12 0.0008
742 RETCHING 18 0.0008
743 CHEST DISCOMFORT 86 0.0008
744 TENDONITIS 13 0.0008
745 DIABETES MELLITUS 64 0.0008
746 DIZZINESS 418 0.0008
747 HAEMOGLOBIN DECREASED 86 0.0008
748 GASTROINTESTINAL DISORDER 75 0.0008
749 BONE PAIN 49 0.0008
750 EJECTION FRACTION DECREASED 13 0.0008
751 ANKYLOSING SPONDYLITIS 11 0.0008
752 SWOLLEN TONGUE 26 0.0008
753 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
754 TRANSIENT ISCHAEMIC ATTACK 28 0.0008
755 ARTHROPATHY 46 0.0008
756 HYPOKINESIA 12 0.0008
757 TREATMENT NONCOMPLIANCE 45 0.0008
758 HAEMATOMA 21 0.0008
759 INSOMNIA 215 0.0008
760 EXTRAPYRAMIDAL DISORDER 20 0.0008
761 RENAL FAILURE ACUTE 34 0.0008
762 BONE LOSS 12 0.0008
763 HEART RATE IRREGULAR 18 0.0008
764 PRODUCT AVAILABILITY ISSUE 18 0.0008
765 HYPOACUSIS 34 0.0008
766 GASTRIC ULCER 15 0.0008
767 FEELING ABNORMAL 189 0.0008
768 HAEMATURIA 27 0.0008
769 INTENTIONAL PRODUCT USE ISSUE 69 0.0008
770 VENTRICULAR TACHYCARDIA 13 0.0008
771 GASTRIC DISORDER 27 0.0008
772 NEUTROPHIL COUNT DECREASED 32 0.0008
773 INCORRECT PRODUCT ADMINISTRATION DURATION 17 0.0008
774 BODY TEMPERATURE INCREASED 16 0.0008
775 FAECES DISCOLOURED 17 0.0008
776 PARAESTHESIA 123 0.0008
777 LYMPHOMA 12 0.0008
778 LUNG INFECTION 12 0.0008
779 BRONCHOSPASM 11 0.0008
780 PLATELET COUNT INCREASED 10 0.0008
781 INTENTIONAL PRODUCT MISUSE 67 0.0008
782 INJECTION SITE PAIN 234 0.0008
783 LYMPHADENOPATHY 27 0.0008
784 VOMITING 358 0.0008
785 INJECTION SITE PRURITUS 51 0.0008
786 RHEUMATOID ARTHRITIS 86 0.0008
787 CARDIAC ARREST 62 0.0008
788 INJECTION SITE ERYTHEMA 93 0.0007
789 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
790 ORTHOSTATIC HYPOTENSION 13 0.0007
791 FEMUR FRACTURE 23 0.0007
792 TYPE 2 DIABETES MELLITUS 25 0.0007
793 TREMOR 123 0.0007
794 PANIC ATTACK 27 0.0007
795 MUSCLE TIGHTNESS 12 0.0007
796 HEART RATE DECREASED 26 0.0007
797 SYNCOPE 74 0.0007
798 ACNE 56 0.0007
799 PANCREATITIS 39 0.0007
800 BRADYCARDIA 39 0.0007
801 DRUG ERUPTION 13 0.0007
802 OSTEONECROSIS 24 0.0007
803 PRODUCT PREPARATION ERROR 15 0.0007
804 SOMNOLENCE 147 0.0007
805 HOT FLUSH 55 0.0007
806 BLOOD CHOLESTEROL INCREASED 34 0.0007
807 CORONARY ARTERY OCCLUSION 10 0.0007
808 PERIPHERAL COLDNESS 10 0.0007
809 HYPONATRAEMIA 41 0.0007
810 HYPERSENSITIVITY 135 0.0007
811 TREATMENT FAILURE 60 0.0007
812 DYSARTHRIA 27 0.0007
813 PHARYNGEAL OEDEMA 11 0.0007
814 LUNG DISORDER 35 0.0007
815 EMOTIONAL DISORDER 22 0.0007
816 BRAIN OEDEMA 9 0.0007
817 KNEE ARTHROPLASTY 15 0.0007
818 ABDOMINAL PAIN LOWER 18 0.0007
819 MOBILITY DECREASED 51 0.0007
820 BLOOD BILIRUBIN INCREASED 19 0.0007
821 MOOD ALTERED 19 0.0007
822 APHASIA 21 0.0007
823 MULTI-ORGAN FAILURE 12 0.0007
824 MUSCLE TWITCHING 16 0.0007
825 DIPLOPIA 18 0.0007
826 INJECTION SITE URTICARIA 17 0.0007
827 C-REACTIVE PROTEIN INCREASED 25 0.0007
828 FRACTURE 13 0.0007
829 CARDIAC FAILURE 55 0.0007
830 DRUG INTOLERANCE 66 0.0007
831 MUSCULOSKELETAL DISORDER 13 0.0007
832 LOSS OF CONSCIOUSNESS 87 0.0007
833 NEUTROPENIA 92 0.0007
834 TACHYCARDIA 60 0.0007
835 GLOSSODYNIA 15 0.0007
836 SPEECH DISORDER 35 0.0007
837 HYPERHIDROSIS 86 0.0007
838 THERAPY CESSATION 34 0.0007
839 MUSCULOSKELETAL STIFFNESS 58 0.0007
840 PALLOR 18 0.0007
841 AMNESIA 43 0.0007
842 HAEMORRHAGE 69 0.0007
843 PRESYNCOPE 16 0.0007
844 CARDIAC DISORDER 61 0.0007
845 ANGER 22 0.0006
846 COORDINATION ABNORMAL 9 0.0006
847 ACUTE MYOCARDIAL INFARCTION 19 0.0006
848 DELUSION 10 0.0006
849 MIDDLE INSOMNIA 12 0.0006
850 BLOOD TEST ABNORMAL 9 0.0006
851 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
852 BLINDNESS UNILATERAL 9 0.0006
853 PRODUCT USE COMPLAINT 10 0.0006
854 CONFUSIONAL STATE 102 0.0006
855 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
856 HALLUCINATION, AUDITORY 10 0.0006
857 ANGINA PECTORIS 18 0.0006
858 SKIN BURNING SENSATION 45 0.0006
859 INJECTION SITE BRUISING 50 0.0006
860 INJECTION SITE REACTION 43 0.0006
861 BLOOD GLUCOSE DECREASED 30 0.0006
862 INJECTION SITE MASS 23 0.0006
863 FEELING HOT 38 0.0006
864 DYSGEUSIA 46 0.0006
865 HALLUCINATION, VISUAL 13 0.0006
866 PLASMA CELL MYELOMA 24 0.0006
867 PULMONARY EMBOLISM 58 0.0006
868 SHOCK 14 0.0006
869 DEMENTIA 17 0.0006
870 PERICARDIAL EFFUSION 14 0.0006
871 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
872 HYPERGLYCAEMIA 22 0.0006
873 COGNITIVE DISORDER 28 0.0006
874 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
875 THROAT TIGHTNESS 16 0.0006
876 ARRHYTHMIA 28 0.0006
877 CIRCULATORY COLLAPSE 10 0.0006
878 DEPRESSED MOOD 31 0.0006
879 STEVENS-JOHNSON SYNDROME 13 0.0006
880 PANCREATITIS ACUTE 13 0.0006
881 FEELING JITTERY 11 0.0006
882 COLD SWEAT 10 0.0006
883 METABOLIC ACIDOSIS 18 0.0006
884 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
885 MOVEMENT DISORDER 18 0.0006
886 PRURITUS GENERALISED 12 0.0006
887 PNEUMONITIS 15 0.0006
888 INFLUENZA LIKE ILLNESS 45 0.0005
889 SUICIDAL IDEATION 50 0.0005
890 DRUG RESISTANCE 14 0.0005
891 ILL-DEFINED DISORDER 33 0.0005
892 URINARY RETENTION 18 0.0005
893 HEPATIC CIRRHOSIS 10 0.0005
894 IRRITABILITY 32 0.0005
895 NEOPLASM MALIGNANT 35 0.0005
896 INCREASED APPETITE 10 0.0005
897 DRUG EFFECT INCOMPLETE 19 0.0005
898 DISTURBANCE IN ATTENTION 28 0.0005
899 DEATH 447 0.0005
900 DRUG INTERACTION 82 0.0005
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 13 0.0005
902 HAEMATEMESIS 13 0.0005
903 CARDIOVASCULAR DISORDER 13 0.0005
904 ADVERSE EVENT 47 0.0005
905 PSYCHOTIC DISORDER 15 0.0005
906 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
907 MOOD SWINGS 16 0.0005
908 CEREBROVASCULAR ACCIDENT 85 0.0005
909 MENTAL IMPAIRMENT 12 0.0005
910 DEVICE BREAKAGE 20 0.0005
911 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
912 LIVER INJURY 12 0.0005
913 BLOOD GLUCOSE ABNORMAL 9 0.0005
914 INJECTION SITE WARMTH 10 0.0005
915 HEPATIC ENZYME INCREASED 33 0.0005
916 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 97 0.0005
917 NERVOUSNESS 25 0.0005
918 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
919 MYELOSUPPRESSION 17 0.0005
920 ABNORMAL DREAMS 13 0.0005
921 DYSKINESIA 19 0.0005
922 NIGHTMARE 16 0.0005
923 CARDIO-RESPIRATORY ARREST 19 0.0005
924 RASH MACULO-PAPULAR 10 0.0004
925 AGITATION 33 0.0004
926 NERVOUS SYSTEM DISORDER 14 0.0004
927 BLOOD GLUCOSE INCREASED 84 0.0004
928 MULTIPLE SCLEROSIS 21 0.0004
929 HYPOGLYCAEMIA 21 0.0004
930 FLUSHING 44 0.0004
931 HEPATITIS 11 0.0004
932 DRUG ADMINISTRATION ERROR 13 0.0004
933 DEVICE ISSUE 37 0.0004
934 NEEDLE ISSUE 12 0.0004
935 RESTLESSNESS 15 0.0004
936 LIVER DISORDER 18 0.0004
937 DISORIENTATION 16 0.0004
938 DELIRIUM 14 0.0004
939 NEOPLASM PROGRESSION 14 0.0004
940 LEUKOPENIA 20 0.0004
941 GENERAL PHYSICAL HEALTH DETERIORATION 46 0.0004
942 EXTRA DOSE ADMINISTERED 16 0.0004
943 BLINDNESS 16 0.0004
944 VISUAL ACUITY REDUCED 13 0.0004
945 ERECTILE DYSFUNCTION 10 0.0004
946 INCORRECT DOSE ADMINISTERED 87 0.0004
947 WITHDRAWAL SYNDROME 16 0.0004
948 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
949 DIABETIC KETOACIDOSIS 9 0.0004
950 VAGINAL HAEMORRHAGE 16 0.0004
951 DEVICE DISLOCATION 16 0.0004
952 CEREBRAL HAEMORRHAGE 13 0.0004
953 DRUG DOSE OMISSION 60 0.0004
954 RESPIRATORY ARREST 10 0.0004
955 ANGIOEDEMA 16 0.0004
956 MYOCARDIAL INFARCTION 61 0.0003
957 MATERNAL EXPOSURE DURING PREGNANCY 31 0.0003
958 DEVICE LEAKAGE 15 0.0003
959 LIVER FUNCTION TEST ABNORMAL 10 0.0003
960 PRODUCT STORAGE ERROR 30 0.0003
961 INTERSTITIAL LUNG DISEASE 16 0.0003
962 UNDERDOSE 24 0.0003
963 ABNORMAL BEHAVIOUR 13 0.0003
964 LUNG NEOPLASM MALIGNANT 13 0.0003
965 ACCIDENTAL OVERDOSE 11 0.0003
966 INJECTION SITE HAEMORRHAGE 24 0.0003
967 RHABDOMYOLYSIS 12 0.0003
968 PRODUCT QUALITY ISSUE 39 0.0003
969 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
970 DRUG DEPENDENCE 45 0.0003
971 ABORTION SPONTANEOUS 11 0.0003
972 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
973 SUICIDE ATTEMPT 16 0.0003
974 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 12 0.0003
975 DEVICE MALFUNCTION 18 0.0003
976 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
977 MULTIPLE SCLEROSIS RELAPSE 17 0.0002
978 OVERDOSE 53 0.0002
979 PRODUCT SUBSTITUTION ISSUE 14 0.0002
980 EXPOSURE DURING PREGNANCY 15 0.0002
981 MEDICATION ERROR 13 0.0002
982 DISEASE RECURRENCE 11 0.0002
983 DRUG WITHDRAWAL SYNDROME 20 0.0002
984 AGGRESSION 11 0.0002
985 DRUG EFFECT DECREASED 11 0.0002
986 CONVULSION 11 0.0002
987 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
988 TOXICITY TO VARIOUS AGENTS 22 0.0001
989 DRUG ABUSE 9 0.0001
990 BREAST CANCER 10 0.0001